Home0P8 • FRA
add
Penumbra Inc
Previous close
€291.00
Day range
€290.60 - €291.70
Year range
€193.10 - €306.40
Market cap
13.36B USD
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Reuters
1 month ago
Boston Scientific beefs up heart device portfolio with $14.5 billion Penumbra deal
1.20%
0.29%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 385.38M | 22.14% |
Operating expense | 202.90M | 20.81% |
Net income | 47.34M | 40.55% |
Net profit margin | 12.28 | 14.98% |
Earnings per share | 1.18 | 21.65% |
EBITDA | 63.49M | 39.16% |
Effective tax rate | 25.60% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 544.82M | 60.18% |
Total assets | 1.83B | 19.13% |
Total liabilities | 398.92M | 4.36% |
Total equity | 1.43B | — |
Shares outstanding | 39.24M | — |
Price to book | 8.00 | — |
Return on assets | 8.29% | — |
Return on capital | 9.19% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 47.34M | 40.55% |
Cash from operations | 86.48M | 69.22% |
Cash from investing | -225.65M | -1,959.76% |
Cash from financing | 5.06M | -16.66% |
Net change in cash | -134.13M | -405.35% |
Free cash flow | 50.26M | 55.13% |
About
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by yearend. Wikipedia
Founded
2004
Website
Employees
4,700
